Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 320
Astellas releases Lexiscan stress agent
By
AuntMinnie.com staff writers
Astellas Pharma U.S. is making Lexiscan (regadenoson) injection available for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging for patients unable to undergo exercise stress.
June 29, 2008
FDG-PET/CT trumps bone scintigraphy for young Hodgkin's lymphoma patients
By
Wayne Forrest
Routine bone scans may be safely eliminated and replaced with FDG-PET/CT in the evaluation of higher-risk children, adolescents, and young adults with Hodgkin's lymphoma, according to a study from St. Jude Children's Research Hospital.
June 29, 2008
FDG-PET changes treatment plans for glioma patients
By
Wayne Forrest
An Australian study is providing evidence that FDG-PET has an important impact on the management of patients with suspected recurrent glioma, and identifies those patients who are more likely to develop progressive disease.
June 25, 2008
Neoprobe launches new gamma detection system
By
AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has introduced a new gamma detection control unit along with Ethicon Endo-Surgery of Cincinnati.
June 24, 2008
Carestream signs Geisinger
By
AuntMinnie.com staff writers
Carestream Health has provided Geisinger Health System with its In-Vivo Multispectral Imaging System FX optical molecular imaging system.
June 22, 2008
AuntMinnie.com Molecular Imaging Insider
By
Wayne Forrest
June 22, 2008
Dilon inks agreement with MedAssets
By
AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has signed a three-year agreement with group purchasing organization MedAssets Supply Chain Systems, a division of MedAssets.
June 18, 2008
Molecular Insight touts Trofex studies
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals is touting the results of three clinical studies of its Trofex prostate cancer detection agent that were presented at the SNM meeting in New Orleans.
June 17, 2008
Medrad gets 510(k) for FDG infusion system
By
AuntMinnie.com staff writers
Contrast injector technology firm Medrad has received 510(k) clearance from the U.S. Food and Drug Administration for Intego, a PET radiopharmaceutical infusion system.
June 17, 2008
SNM cites regulatory, reimbursement, and research as top priorities
By
Wayne Forrest
NEW ORLEANS - SNM is targeting its own version of the three R's -- regulatory, reimbursement, and research -- in its list of priorities in the coming year. Robert Atcher, Ph.D., and Dr. Alexander McEwan discussed these and other issues on Tuesday at the 2008 SNM annual meeting.
June 17, 2008
SNM protests CMS radiopharm bundling
By
AuntMinnie.com staff writers
The SNM believes that a move by the Centers for Medicare and Medicaid Services to bundle reimbursement for radiopharmaceuticals into payment for nuclear medicine procedures could result in reduced patient access for imaging studies.
June 16, 2008
SNM's Images of the Year; radiotherapy and prostate cancer
By
Brian Casey
June 16, 2008
Previous Page
Page 320 of 438
Next Page